ChloroquineV1, Main, Exploration, bibRecord, 002535

Idiopathic inflammatory muscle disease: clinical aspects

Identifieur interne : 002535 ( Main/Exploration ); précédent : 002534; suivant : 002536

Idiopathic inflammatory muscle disease: clinical aspects

Auteurs : Lisa G. Rider [États-Unis] ; Frederick W. Miller [États-Unis]

Source :

Best Practice & Research Clinical Rheumatology [ 1521-6942 ] ; 2000.

RBID : ISTEX:D234F761A3FBB5C9F128A1BB771C6A712B1D71C6

English descriptors

KwdEn :
- autoantibody, classification, myositis, prognosis.
Teeft :
- Abnormality, Acute onset, Adult myositis, Adult patients, American academy, Arthritis, Autoantibody, Cardiac involvement, Case reports, Childhood health assessment questionnaire, Childhood myositis assessment scale, Clinical aspects, Clinical features, Clinicopathological, Clinicopathological subsets, Connective tissue disease, Current opinion, Cutaneous, Dermatology, Dermatomyositis, Disease activity, Disease damage, Extramuscular, Functional assessment, Global disease activity, Idiopathic, Idiopathic myopathies, Interstitial, Interstitial lung disease, Juvenile dermatomyositis, Juvenile idiopathic myopathies, Juvenile myositis, Lactate dehydrogenase, Magnetic resonance imaging, Malignancy, Methotrexate, Msas, Muscle biopsies, Muscle disease, Muscle enzymes, Muscle involvement, Muscle strength, Muscle weakness, Myopathy, Myositis, Myositis disease activity, Myositis patients, Myositis syndromes, Overlap myositis, Polymyositis, Poor prognostic factors, Poor responses, Prognosis, Prognostic, Proximal score, Rash, Rheumatic disease clinics, Rheumatology, Serological, Serological groups, Serological subsets, Serum muscle enzymes, Severe myositis, Subclinical muscle involvement, Subset, Syndrome.

Abstract

Abstract: Although much remains to be learned about the immune-mediated myositis syndromes, information generated from recent studies in a number of areas may assist physicians in patient management. Topics reviewed here include: data supporting the association of myositis with cancer and the appropriate evaluations for malignancy in a myositis patient; an approach to the assessment of patients with dermatomyositis sine myositis; the usefulness of the clinicopathological and serological classifications; a discussion of whether childhood and adult myositis are the same or different entities; a review of those prognostic factors to consider in the clinical management of myositis patients; current approaches and their limitations for assessing disease activity and damage. To improve our limited understanding of the myositis syndromes, national and international collaborations are needed to obtain the necessary numbers of subjects, given the rarity and heterogeneity of these disorders.

Url:

https://api.istex.fr/ark:/67375/6H6-1QNC647H-C/fulltext.pdf

DOI: 10.1053/berh.1999.0076

Affiliations:

États-Unis

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 001D69
to stream Istex, to step Curation: 001D69
to stream Istex, to step Checkpoint: 001353
to stream Main, to step Merge: 002563
to stream Main, to step Curation: 002535

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Idiopathic inflammatory muscle disease: clinical aspects</title>
<author><name sortKey="Rider, Lisa G" sort="Rider, Lisa G" uniqKey="Rider L" first="Lisa G." last="Rider">Lisa G. Rider</name>
</author>
<author><name sortKey="Miller, Frederick W" sort="Miller, Frederick W" uniqKey="Miller F" first="Frederick W." last="Miller">Frederick W. Miller</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D234F761A3FBB5C9F128A1BB771C6A712B1D71C6</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1053/berh.1999.0076</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-1QNC647H-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001D69</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001D69</idno>
<idno type="wicri:Area/Istex/Curation">001D69</idno>
<idno type="wicri:Area/Istex/Checkpoint">001353</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001353</idno>
<idno type="wicri:doubleKey">1521-6942:2000:Rider L:idiopathic:inflammatory:muscle</idno>
<idno type="wicri:Area/Main/Merge">002563</idno>
<idno type="wicri:Area/Main/Curation">002535</idno>
<idno type="wicri:Area/Main/Exploration">002535</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Idiopathic inflammatory muscle disease: clinical aspects</title>
<author><name sortKey="Rider, Lisa G" sort="Rider, Lisa G" uniqKey="Rider L" first="Lisa G." last="Rider">Lisa G. Rider</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Molecular and Developmental Immunology, Center for Biologics Evaluation and Research, Food and Drug Administration, Building 29B, Room 2G11, HFM-561, 8800 Rockville Pike, Bethesda, MD, 20892</wicri:regionArea>
<wicri:noRegion>20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miller, Frederick W" sort="Miller, Frederick W" uniqKey="Miller F" first="Frederick W." last="Miller">Frederick W. Miller</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Molecular and Developmental Immunology, Center for Biologics Evaluation and Research, Food and Drug Administration, Building 29B, Room 2G11, HFM-561, 8800 Rockville Pike, Bethesda, MD, 20892</wicri:regionArea>
<wicri:noRegion>20892</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Best Practice & Research Clinical Rheumatology</title>
<title level="j" type="abbrev">YBERH</title>
<idno type="ISSN">1521-6942</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2000">2000</date>
<biblScope unit="volume">14</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="37">37</biblScope>
<biblScope unit="page" to="54">54</biblScope>
</imprint>
<idno type="ISSN">1521-6942</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1521-6942</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>autoantibody</term>
<term>classification</term>
<term>myositis</term>
<term>prognosis</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abnormality</term>
<term>Acute onset</term>
<term>Adult myositis</term>
<term>Adult patients</term>
<term>American academy</term>
<term>Arthritis</term>
<term>Autoantibody</term>
<term>Cardiac involvement</term>
<term>Case reports</term>
<term>Childhood health assessment questionnaire</term>
<term>Childhood myositis assessment scale</term>
<term>Clinical aspects</term>
<term>Clinical features</term>
<term>Clinicopathological</term>
<term>Clinicopathological subsets</term>
<term>Connective tissue disease</term>
<term>Current opinion</term>
<term>Cutaneous</term>
<term>Dermatology</term>
<term>Dermatomyositis</term>
<term>Disease activity</term>
<term>Disease damage</term>
<term>Extramuscular</term>
<term>Functional assessment</term>
<term>Global disease activity</term>
<term>Idiopathic</term>
<term>Idiopathic myopathies</term>
<term>Interstitial</term>
<term>Interstitial lung disease</term>
<term>Juvenile dermatomyositis</term>
<term>Juvenile idiopathic myopathies</term>
<term>Juvenile myositis</term>
<term>Lactate dehydrogenase</term>
<term>Magnetic resonance imaging</term>
<term>Malignancy</term>
<term>Methotrexate</term>
<term>Msas</term>
<term>Muscle biopsies</term>
<term>Muscle disease</term>
<term>Muscle enzymes</term>
<term>Muscle involvement</term>
<term>Muscle strength</term>
<term>Muscle weakness</term>
<term>Myopathy</term>
<term>Myositis</term>
<term>Myositis disease activity</term>
<term>Myositis patients</term>
<term>Myositis syndromes</term>
<term>Overlap myositis</term>
<term>Polymyositis</term>
<term>Poor prognostic factors</term>
<term>Poor responses</term>
<term>Prognosis</term>
<term>Prognostic</term>
<term>Proximal score</term>
<term>Rash</term>
<term>Rheumatic disease clinics</term>
<term>Rheumatology</term>
<term>Serological</term>
<term>Serological groups</term>
<term>Serological subsets</term>
<term>Serum muscle enzymes</term>
<term>Severe myositis</term>
<term>Subclinical muscle involvement</term>
<term>Subset</term>
<term>Syndrome</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: Although much remains to be learned about the immune-mediated myositis syndromes, information generated from recent studies in a number of areas may assist physicians in patient management. Topics reviewed here include: data supporting the association of myositis with cancer and the appropriate evaluations for malignancy in a myositis patient; an approach to the assessment of patients with dermatomyositis sine myositis; the usefulness of the clinicopathological and serological classifications; a discussion of whether childhood and adult myositis are the same or different entities; a review of those prognostic factors to consider in the clinical management of myositis patients; current approaches and their limitations for assessing disease activity and damage. To improve our limited understanding of the myositis syndromes, national and international collaborations are needed to obtain the necessary numbers of subjects, given the rarity and heterogeneity of these disorders.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Rider, Lisa G" sort="Rider, Lisa G" uniqKey="Rider L" first="Lisa G." last="Rider">Lisa G. Rider</name>
</noRegion>
<name sortKey="Miller, Frederick W" sort="Miller, Frederick W" uniqKey="Miller F" first="Frederick W." last="Miller">Frederick W. Miller</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002535 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002535 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D234F761A3FBB5C9F128A1BB771C6A712B1D71C6
   |texte=   Idiopathic inflammatory muscle disease: clinical aspects
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

Idiopathic inflammatory muscle disease: clinical aspects

Idiopathic inflammatory muscle disease: clinical aspects

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri